CHAM
KZR

Clear Harbor Asset Management’s Kezar Life Sciences KZR Stock Holding History

Clear Harbor Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,805
Closed -$77.1K – 430
2025
Q1 		$77.1K Buy
+15,805
New +$95.9K 0.01% 394

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Clear Harbor Asset Management's KZR Position: Q2 2025 in Review

Clear Harbor Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2025, closing a stake of 15,805 shares — an estimated $77.1K sold.

Clear Harbor Asset Management first reported a position in KZR in Q1 2025 and held it in 1 quarter. The position peaked at $77.1K in Q1 2025. 40 funds tracked by Wall St. Rank hold KZR as of Q2 2025.

  • Clear Harbor Asset Management reported no remaining Kezar Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Clear Harbor Asset Management sold 15,805 Kezar Life Sciences shares in Q2 2025, an estimated $77.1K.
  • Clear Harbor Asset Management first reported a position in Kezar Life Sciences in Q1 2025 and held it in 1 quarter.
  • Clear Harbor Asset Management's Kezar Life Sciences position peaked at $77.1K in Q1 2025.
  • 40 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2025.

Based on Clear Harbor Asset Management's 13F filing for Q2 2025, filed 14 Jul 2025.